Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × olaparib × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Sarcoma 1 Breast 1

Conditions

Breast Neoplasms 60 Triple Negative Breast Neoplasms 26 Ovarian Neoplasms 16 Neoplasm Metastasis 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 6 Fanconi Anemia, Complementation Group D1 4 Endometrial Neoplasms 4 Advanced Breast Cancer 4 Recurrence 3 Neoplasms 3 Small Cell Lung Carcinoma 2 Inflammatory Breast Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Metastatic Breast Cancer 1 Thyroid Neoplasms 1 Thrombocytosis 1 Stomach Neoplasms 1 Sarcoma 1 Radiation Injuries 1 Primary Myelofibrosis 1 Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Trastuzumab 16 Radiosurgery 14 Capecitabine 12 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Lapatinib 9 trastuzumab deruxtecan 7 Temozolomide 6 tucatinib 4 pembrolizumab 4 paclitaxel-Angiopep-2 conjugate 4 eribulin 4 Specimen Handling 4 Methotrexate 4 Cisplatin 4 pyrotinib 3 Vinorelbine 3 Radiation 3 Paclitaxel 3 Fluorodeoxyglucose F18 3 sacituzumab govitecan 2 pertuzumab 2 palbociclib 2 neratinib 2 durvalumab 2 cediranib 2 cabazitaxel 2 abemaciclib 2 Sodium Chloride 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡